盘点爱康国宾涉诉情况：曾被判赔偿当事人10万元

Core Viewpoint - The controversy surrounding iKang Guobin arises from customer complaints regarding potential misdiagnosis and missed diagnoses in health checkups, leading to legal actions against the company [2][3]. Group 1: Customer Complaints and Legal Actions - Customer Zhang has accused iKang Guobin of misdiagnosis and missed diagnosis after being diagnosed with cancer in 2024 despite having no prior warnings during ten years of checkups [3]. - Similar lawsuits have been noted, with previous cases showing mixed outcomes for both customers and iKang Guobin [3]. - The company has publicly denied the allegations, asserting that the claims are unfounded and have harmed its employees, and has initiated legal proceedings against Zhang [2]. Group 2: Court Rulings and Precedents - A court ruling found that iKang Guobin failed to detect a liver hemangioma during a checkup, leading to a customer being awarded 500 yuan for additional examination costs [4]. - In another case, iKang Guobin was ordered to pay a total of 100,000 yuan to a customer who was diagnosed with cervical cancer after previous checkups showed no abnormalities, establishing a link between the company's negligence and the delayed diagnosis [5]. - Conversely, in a separate case, a customer’s claim was dismissed due to insufficient evidence linking the health check to subsequent medical issues, highlighting the complexity of such legal disputes [6]. Group 3: Company’s Position and Response - iKang Guobin maintains that its health check reports are accurate and that it is willing to accept third-party evaluations to validate its procedures and findings [6].